An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study - Geisen, C; Kjaer, M; Fleck, E (J Thromb Haemost, 2023)